Meeting
2019 ASCO Annual Meeting
Relationship of emergency department use pre- and post-cancer diagnosis in safety-net adults.
Authors
Arthur Hong
University of Texas Southwestern Medical Center, Dallas, TX
Arthur Hong , Navid Sadeghi , John Vernon Cox , Simon Craddock Lee , Ethan Halm
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research, Clinical Informatics, and Quality of Care
Track
Quality Care/Health Services Research
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 37, 2019 (suppl; abstr 6626)
DOI
10.1200/JCO.2019.37.15_suppl.6626
Abstract #
6626
Poster Bd #
317
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
VIC regimen (vemurafenib/irinotecan/cetuximab) versus bevacizumab plus chemotherapy as first-line treatment for BRAF V600E-mutated advanced colorectal cancer.
First Author: Yijiao Chen
Poster
2023 ASCO Annual Meeting
A phase Ib/II study to evaluate surufatinib combined with camrelizumab and chemotherapy in the second-line treatment of advanced colorectal cancer: Phase Ib results.
First Author: Sheng Li
Poster
2023 ASCO Gastrointestinal Cancers Symposium
WU-NK-101, an enhanced memory natural killer (NK) cell therapy, with cetuximab (Ctx) for the treatment of advanced colorectal cancer (CRC).
First Author: John Muth
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Use of circulating tumor DNA (ctDNA) for early assessment of treatment response in patients with advanced colorectal cancer (aCRC): A real-world (RW) analysis.
First Author: Pashtoon Murtaza Kasi